ABATACEPT Side Effects

7013419-X | Cholecystitis
on Sep 22, 2010 Male patient from NETHERLANDS , 70 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Abatacept (View Usage). Patient experienced the following unwanted or unexpected effects: cholecystitis. Abatacept dosage: 1 Df:125 Unit Not Specified. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), VITAMIN B 12 (Inj) (View Vitamin B-12 Review and Vitamin B-12 Label ), CARDIOX (View Cardiox Review and Cardiox Label ). Patient was hospitalized.

7004954-9 | Leukopenia
Patient was taking Abatacept (View Usage). Patient had the following side effects: leukopenia on Sep 20, 2010 from CHINA Additional patient health information: Female patient , 52 years of age, was diagnosed with systemic lupus erythematosus and. Abatacept dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), PARIET (View Pariet Review and Pariet Label ), RAMIPRIL (1df=2.5mg/1.5mg) (View Ramipril Review and Ramipril Label ), STILNOX (View Stilnox Review and Stilnox Label ). Patient was hospitalized.

6999797-6 | Anaemia, Lower Respiratory Tract Infection, Renal Failure
Adverse event was reported on Sep 16, 2010 by a Female patient taking Abatacept (View Usage) (Dosage: ) was diagnosed with systemic lupus erythematosus and. Location: INDIA , 25 years of age, After Abatacept was administered, patient had the following side effects: anaemia, lower respiratory tract infection, renal failure. During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), WYSOLONE (View Wysolone Review and Wysolone Label ), PANTOCID (Tablet) (View Pantocid Review and Pantocid Label ), EPTOIN (2 Tab At Night) (View Eptoin Review and Eptoin Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), HYDROXYCHLOROQUINE (View Hydroxychloroquine Review and Hydroxychloroquine Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), FOLATE (Tablet) (View Folate Review and Folate Label ). Patient was hospitalized.

6993032-0 | Osteonecrosis
on Sep 16, 2010 Female patient from INDIA , 29 years of age, was diagnosed with systemic lupus erythematosus and was treated with Abatacept (View Usage). Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?). Abatacept dosage: . During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ETORICOXIB (View Etoricoxib Review and Etoricoxib Label ), HYDROXYCHLOROQUINE (View Hydroxychloroquine Review and Hydroxychloroquine Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ). Patient was hospitalized.


6973061-3 | Optic Neuritis
on Aug 30, 2010 Female patient from INDIA , 37 years of age, was diagnosed with glomerulonephritis proliferative and was treated with Abatacept (View Usage). Patient had the following side effects: optic neuritis. Abatacept dosage: . During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), HYDROXYCHLOROQUINE (View Hydroxychloroquine Review and Hydroxychloroquine Label ). Patient was hospitalized.

6969085-2 | Anaemia
Patient was taking Abatacept (View Usage). After Abatacept was administered, patient had the following side effects: anaemia on Sep 01, 2010 from RUSSIAN FEDERATION Additional patient health information: Female patient , 13 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Abatacept dosage: . During the same period patient was treated with METYPRED (View Metypred Review and Metypred Label ), NIMESULIDE (1 Df=150 Units Not Specified) (View Nimesulide Review and Nimesulide Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6967553-0 | Leukopenia
Adverse event was reported on Sep 03, 2010 by a Female patient taking Abatacept (View Usage) (Dosage: ) was diagnosed with systemic lupus erythematosus and. Location: CHINA , 52 years of age, Patient experienced the following unwanted or unexpected effects: leukopenia. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), PARIET (View Pariet Review and Pariet Label ), RAMIPRIL (1df=2.5mg/1.5mg) (View Ramipril Review and Ramipril Label ), STILNOX (View Stilnox Review and Stilnox Label ). Patient was hospitalized.

6962784-8 | Cholecystitis Acute
on Aug 27, 2010 Female patient from ARGENTINA , 47 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Abatacept (View Usage). Patient had the following side effects: cholecystitis acute. Abatacept dosage: Interrupted On 24aug10 No Of Courses 55. During the same period patient was treated with METHOTREXATE (Continued) (View Methotrexate Review and Methotrexate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ). Patient was hospitalized.

6961176-5 | Anaemia, Lower Respiratory Tract Infection, Renal Failure
on Aug 26, 2010 Female patient from INDIA , 25 years of age, was diagnosed with systemic lupus erythematosus and was treated with Abatacept (View Usage). After Abatacept was administered, patient had the following side effects: anaemia, lower respiratory tract infection, renal failure. Abatacept dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), WYSOLONE (View Wysolone Review and Wysolone Label ), PANTOCID (Tablet) (View Pantocid Review and Pantocid Label ), EPTOIN (2 Tab At Night) (View Eptoin Review and Eptoin Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), HYDROXYCHLOROQUINE (View Hydroxychloroquine Review and Hydroxychloroquine Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), FOLATE (Tablet) (View Folate Review and Folate Label ). Patient was hospitalized.

6955350-1 | Endophthalmitis
Patient was taking Abatacept (View Usage). Patient experienced the following unwanted or unexpected effects: endophthalmitis on Aug 20, 2010 from UNITED STATES Additional patient health information: Male patient , 58 years of age, . Abatacept dosage: 12th Infusion.

6939194-2 | Diverticular Perforation, Endocarditis, Sepsis, Wound Dehiscence
Adverse event was reported on Aug 19, 2010 by a Female patient taking Abatacept (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: GERMANY , 73 years of age, weighting 167.6 lb, Patient had the following side effects: diverticular perforation, endocarditis (What is endocarditis?), sepsis (What is sepsis?), wound dehiscence. Patient was hospitalized.

6936859-3 | Lupus Nephritis, Renal Colic
on Aug 18, 2010 Female patient from ARGENTINA , 32 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Abatacept (View Usage). After Abatacept was administered, patient had the following side effects: lupus nephritis, renal colic. Abatacept dosage: Also Taken Via Sc At Dose 250mg From 15jul2008-cont (109 Courses).. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), MODURETIC 5 50 (View Moduretic 5-50 Review and Moduretic 5-50 Label ), ESTROGEN (View Estrogen Review and Estrogen Label ), PROGESTERONE (View Progesterone Review and Progesterone Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ). Patient was hospitalized.

6932598-3 | Leukopenia
on Aug 16, 2010 Female patient from CHINA , 52 years of age, was diagnosed with systemic lupus erythematosus and was treated with Abatacept (View Usage). Patient experienced the following unwanted or unexpected effects: leukopenia. Abatacept dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), RAMIPRIL (1df=2.5mg/1.5mg) (View Ramipril Review and Ramipril Label ), STILNOX (View Stilnox Review and Stilnox Label ). Patient was hospitalized.

6932591-0 | Glomerulonephritis, Renal Colic
Patient was taking Abatacept (View Usage). Patient had the following side effects: glomerulonephritis, renal colic on Aug 13, 2010 from ARGENTINA Additional patient health information: Female patient , 32 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Abatacept dosage: Also Taken Via Sc At Dose 250mg From 15jul2008-cont.. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), MODURETIC 5 50 (View Moduretic 5-50 Review and Moduretic 5-50 Label ), ESTROGEN (View Estrogen Review and Estrogen Label ), PROGESTERONE (View Progesterone Review and Progesterone Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ). Patient was hospitalized.

6909059-0 | Diverticular Perforation, Endocarditis Bacterial
Adverse event was reported on Aug 03, 2010 by a Female patient taking Abatacept (View Usage) (Dosage: T0(12jan09)750mg;t1(16apr2009)750mg; T2(09jul2009) 750 Mg) . Location: GERMANY , 73 years of age, After Abatacept was administered, patient had the following side effects: diverticular perforation, endocarditis bacterial. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), CORIFEO (View Corifeo Review and Corifeo Label ), BERODUAL (View Berodual Review and Berodual Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), DOXEPIN HCL (View Doxepin Hcl Review and Doxepin Hcl Label ), CELEBREX (View Celebrex Review and Celebrex Label ). Patient was hospitalized.

6908203-9 | Peritoneal Tuberculosis
on Jul 30, 2010 Male patient from ARGENTINA , 57 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Abatacept (View Usage). Patient experienced the following unwanted or unexpected effects: peritoneal tuberculosis. Abatacept dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ). Patient was hospitalized.

6905557-4 | Aortic Valve Disease, Basal Cell Carcinoma, Cardiogenic Shock, Endocarditis, Osteonecrosis Of Jaw, Sepsis, Skin Cancer, Skin Ulcer
on Jul 27, 2010 Male patient from GERMANY , 69 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Abatacept (View Usage). Patient had the following side effects: aortic valve disease, basal cell carcinoma, cardiogenic shock, endocarditis (What is endocarditis?), osteonecrosis of jaw, sepsis (What is sepsis?), skin cancer (What is skin cancer?), skin ulcer. Abatacept dosage: Also Taken In Aug 2008. During the same period patient was treated with INFLIXIMAB (View Infliximab Review and Infliximab Label ), ARAVA (10mg Once A Day From Aug-2007) (View Arava Review and Arava Label ), PENICILLAMINE (View Penicillamine Review and Penicillamine Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), DECORTIN H (View Decortin-h Review and Decortin-h Label ), FOSAVANCE (View Fosavance Review and Fosavance Label ), MARCUMAR (View Marcumar Review and Marcumar Label ). Patient was hospitalized.

6899940-3 | Asthenia, Dizziness, Major Depression, Nasopharyngitis, Panic Attack
Patient was taking Abatacept (View Usage). After Abatacept was administered, patient had the following side effects: asthenia, dizziness (What is dizziness?), major depression, nasopharyngitis, panic attack on Jul 27, 2010 from GERMANY Additional patient health information: Female patient , 73 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Abatacept dosage: Inter:jan09,restd:5mar09,inte:19oct09(cumulative Dose:nov08-oct09:8250 Mg)restr:5may09 Also14jan10. During the same period patient was treated with METHOTREXATE (Interr And Resrted On Feb2009) (View Methotrexate Review and Methotrexate Label ), METHYLPREDNISOLONE (Before 2003) (View Methylprednisolone Review and Methylprednisolone Label ), CALCIUM CARBONATE + CHOLECALCIFEROL (Before 2003 Calcilac) (View Calcium Carbonate + Cholecalciferol Review and Calcium Carbonate + Cholecalciferol Label ), BISOPROLOL (Bisoprolol 5) (View Bisoprolol Review and Bisoprolol Label ), INSPRA (Inspra 25) (View Inspra Review and Inspra Label ), PANTOZOL (Pantozol 20) (View Pantozol Review and Pantozol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FLUVASTATIN (Locol 80) (View Fluvastatin Review and Fluvastatin Label ). Patient was hospitalized.

6894644-5 | Diverticular Perforation, Endocarditis Bacterial
Adverse event was reported on Jul 27, 2010 by a Female patient taking Abatacept (View Usage) (Dosage: T0(12jan09)750mg;t1(16apr2009)750mg; T2(09jul2009) 750 Mg) . Location: GERMANY , 73 years of age, Patient experienced the following unwanted or unexpected effects: diverticular perforation, endocarditis bacterial. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), CORIFEO (View Corifeo Review and Corifeo Label ), BERODUAL (View Berodual Review and Berodual Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), DOXEPIN HCL (View Doxepin Hcl Review and Doxepin Hcl Label ), CELEBREX (View Celebrex Review and Celebrex Label ). Patient was hospitalized.

6883572-7 | Aortic Valve Disease, Basal Cell Carcinoma, Cardiogenic Shock, Endocarditis, Osteonecrosis Of Jaw, Sepsis, Skin Cancer, Skin Ulcer
on Jul 22, 2010 Male patient from GERMANY , 69 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Abatacept (View Usage). Patient had the following side effects: aortic valve disease, basal cell carcinoma, cardiogenic shock, endocarditis (What is endocarditis?), osteonecrosis of jaw, sepsis (What is sepsis?), skin cancer (What is skin cancer?), skin ulcer. Abatacept dosage: Also Taken In Aug 2008. During the same period patient was treated with INFLIXIMAB (View Infliximab Review and Infliximab Label ), ARAVA (10mg Once A Day From Aug-2007) (View Arava Review and Arava Label ), PENICILLAMINE (View Penicillamine Review and Penicillamine Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), DECORTIN H (View Decortin-h Review and Decortin-h Label ), FOSAVANCE (View Fosavance Review and Fosavance Label ), MARCUMAR (View Marcumar Review and Marcumar Label ). Patient was hospitalized.

6880876-9 | Atrial Fibrillation, Cardiac Failure, Foot Deformity, Mitral Valve Incompetence
on Jul 21, 2010 Female patient from JAPAN , 49 years of age, weighting 119.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), prophylaxis, prophylaxis against gastrointestinal ulcer and was treated with Abatacept (View Usage). After Abatacept was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cardiac failure, foot deformity, mitral valve incompetence. Abatacept dosage: . During the same period patient was treated with PREDONINE (12sep09 5mg Sid) (View Predonine Review and Predonine Label ), RHEUMATREX (Formulation - Capsule Rheumatrex Tab 4mg/wk Po 05dec09-24jan10) (View Rheumatrex Review and Rheumatrex Label ), LORCAM (Formulation - Tablet) (View Lorcam Review and Lorcam Label ), FOLIAMIN (Formulation - Tablet From 07dec09) (View Foliamin Review and Foliamin Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), FLURBIPROFEN (View Flurbiprofen Review and Flurbiprofen Label ), MUCOSTA (Formulation - Tablet Tab 150mg/day Po) (View Mucosta Review and Mucosta Label ). Patient was hospitalized.

6866394-2 | Viral Infection
Patient was taking Abatacept (View Usage). Patient experienced the following unwanted or unexpected effects: viral infection (What is viral infection?) on Jul 19, 2010 from HUNGARY Additional patient health information: Female patient , 20 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Abatacept dosage: Interrupted On 01mar2010. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6863160-9 | Endophthalmitis
Adverse event was reported on Jul 15, 2010 by a Male patient taking Abatacept (View Usage) (Dosage: 12th Infusion) . Location: UNITED STATES , 58 years of age, Patient had the following side effects: endophthalmitis.

6860083-6 | Appendicitis
on Jul 15, 2010 Female patient from MEXICO , 38 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Abatacept (View Usage). After Abatacept was administered, patient had the following side effects: appendicitis (What is appendicitis?). Abatacept dosage: 1 Dosage Form: 125 Mg/ml. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ). Patient was hospitalized.

6856011-X | Endophthalmitis
on Jul 13, 2010 Male patient from UNITED STATES , 58 years of age, was treated with Abatacept (View Usage). Patient experienced the following unwanted or unexpected effects: endophthalmitis. Abatacept dosage: .

6848589-7 | Urinary Tract Infection, Urosepsis
Patient was taking Abatacept (View Usage). Patient had the following side effects: urinary tract infection (What is urinary tract infection?), urosepsis on Jul 14, 2010 from POLAND Additional patient health information: Female patient , 57 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Abatacept dosage: Also On 26feb09,int:13aug09; Restarted:14aug09,int:10jun09(125 Units Nos) 1df: 750 Unit Nos(iv). During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), METYPRED (View Metypred Review and Metypred Label ), DICLAC (View Diclac Review and Diclac Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), TIALORID (View Tialorid Review and Tialorid Label ), ZOCOR (View Zocor Review and Zocor Label ), CALCIUM (View Calcium Review and Calcium Label ), ALPHACALCIDOL (View Alphacalcidol Review and Alphacalcidol Label ). Patient was hospitalized.

6840139-4 | Anaemia, Lower Respiratory Tract Infection, Renal Failure
Adverse event was reported on Jul 08, 2010 by a Female patient taking Abatacept (View Usage) (Dosage: ) was diagnosed with systemic lupus erythematosus and. Location: INDIA , 25 years of age, After Abatacept was administered, patient had the following side effects: anaemia, lower respiratory tract infection, renal failure. During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), PANTOCID (View Pantocid Review and Pantocid Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), HYDROXYCHLOROQUINE (View Hydroxychloroquine Review and Hydroxychloroquine Label ), ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ). Patient was hospitalized.

6836462-X | Asthenia, Dizziness, Major Depression, Nasopharyngitis, Panic Attack
on Jul 06, 2010 Female patient from GERMANY , 73 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Abatacept (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, dizziness (What is dizziness?), major depression, nasopharyngitis, panic attack. Abatacept dosage: Interr:jan09,resrted:mar09 Inte:19oct09(cumulative Dose:nov08 To Oct09:8250 Mg)restar:14jan2010. During the same period patient was treated with METHOTREXATE (Interr And Resrted On Feb2009) (View Methotrexate Review and Methotrexate Label ), METHYLPREDNISOLONE (Before 2003) (View Methylprednisolone Review and Methylprednisolone Label ), CALCIUM CARBONATE + CHOLECALCIFEROL (Before 2003 Calcilac) (View Calcium Carbonate + Cholecalciferol Review and Calcium Carbonate + Cholecalciferol Label ), BISOPROLOL (Bisoprolol 5) (View Bisoprolol Review and Bisoprolol Label ), INSPRA (Inspra 25) (View Inspra Review and Inspra Label ), PANTOZOL (Pantozol 20) (View Pantozol Review and Pantozol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FLUVASTATIN (Locol 80) (View Fluvastatin Review and Fluvastatin Label ). Patient was hospitalized.

6832074-2 | Vomiting
on Jul 07, 2010 Female patient from POLAND , 57 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Abatacept (View Usage). Patient had the following side effects: vomiting. Abatacept dosage: Interrupted On 13aug09 1df: 750 Unit Nos. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), METYPRED (View Metypred Review and Metypred Label ), DICLAC (View Diclac Review and Diclac Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), TIALORID (View Tialorid Review and Tialorid Label ), ZOCOR (View Zocor Review and Zocor Label ), CALCIUM (View Calcium Review and Calcium Label ), ALPHACALCIDOL (View Alphacalcidol Review and Alphacalcidol Label ). Patient was hospitalized.

6832060-2 | Anaemia, Lower Respiratory Tract Infection, Renal Failure
Patient was taking Abatacept (View Usage). After Abatacept was administered, patient had the following side effects: anaemia, lower respiratory tract infection, renal failure on Jul 03, 2010 from INDIA Additional patient health information: Female patient , 25 years of age, was diagnosed with systemic lupus erythematosus and. Abatacept dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), PANTOCID (View Pantocid Review and Pantocid Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), HYDROXYCHLOROQUINE (View Hydroxychloroquine Review and Hydroxychloroquine Label ), ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ). Patient was hospitalized.

6818856-1 | Vomiting
Adverse event was reported on Jun 29, 2010 by a Female patient taking Abatacept (View Usage) (Dosage: Interrupted On 13aug09 1df: 750 Unit Nos) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: POLAND , 57 years of age, Patient experienced the following unwanted or unexpected effects: vomiting. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), METYPRED (View Metypred Review and Metypred Label ), DICLAC (View Diclac Review and Diclac Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), TIALORID (View Tialorid Review and Tialorid Label ), ZOCOR (View Zocor Review and Zocor Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), ALPHACALCIDOL (View Alphacalcidol Review and Alphacalcidol Label ). Patient was hospitalized.

6818854-8 | Anaemia, Renal Failure
on Jun 30, 2010 Female patient from INDIA , 25 years of age, was diagnosed with systemic lupus erythematosus and was treated with Abatacept (View Usage). Patient had the following side effects: anaemia, renal failure. Abatacept dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), PANTOCID (View Pantocid Review and Pantocid Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), HYDROXYCHLOROQUINE (View Hydroxychloroquine Review and Hydroxychloroquine Label ), ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ). Patient was hospitalized.

6817879-6 | Confusional State, Haematoma, Petechiae
on Jul 01, 2010 Female patient from ARGENTINA , 60 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Abatacept (View Usage). After Abatacept was administered, patient had the following side effects: confusional state, haematoma, petechiae. Abatacept dosage: 3 Vials. Patient was hospitalized.

6816206-8 | Diverticular Perforation, Diverticulitis, Endocarditis Bacterial, Endocarditis Staphylococcal
Patient was taking Abatacept (View Usage). Patient experienced the following unwanted or unexpected effects: diverticular perforation, diverticulitis, endocarditis bacterial, endocarditis staphylococcal on Jun 29, 2010 from GERMANY Additional patient health information: Female patient , 73 years of age, . Abatacept dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), CORIFEO (View Corifeo Review and Corifeo Label ), BERODUAL (View Berodual Review and Berodual Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), DOXEPIN HCL (View Doxepin Hcl Review and Doxepin Hcl Label ), CELEBREX (View Celebrex Review and Celebrex Label ). Patient was hospitalized.

6812913-1 | Abdominal Pain, Vomiting
Adverse event was reported on Jun 29, 2010 by a Female patient taking Abatacept (View Usage) (Dosage: Interrupted On 13aug09 1df: 750 Unit Nos) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: POLAND , 57 years of age, Patient had the following side effects: abdominal pain (What is abdominal pain?), vomiting. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), METYPRED (View Metypred Review and Metypred Label ), DICLAC (View Diclac Review and Diclac Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), TIALORID (View Tialorid Review and Tialorid Label ), ZOCOR (View Zocor Review and Zocor Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), ALPHACALCIDOL (View Alphacalcidol Review and Alphacalcidol Label ). Patient was hospitalized.

6810286-1 | Disturbance In Attention, Spinal Column Stenosis
on Jun 18, 2010 Female patient from AUSTRALIA , 73 years of age, was treated with Abatacept (View Usage). After Abatacept was administered, patient had the following side effects: disturbance in attention, spinal column stenosis. Abatacept dosage: Last Inf: 15-june-2010. Patient was hospitalized.

6805753-0 | Appendicitis
on Jun 24, 2010 Male patient from UNITED STATES , 61 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Abatacept (View Usage). Patient experienced the following unwanted or unexpected effects: appendicitis (What is appendicitis?). Abatacept dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), FLOMAX (View Flomax Review and Flomax Label ), FLUTICASONE (View Fluticasone Review and Fluticasone Label ), EXCEDRIN (MIGRAINE) (View Excedrin (migraine) Review and Excedrin (migraine) Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6796417-0 | Dehydration, Diarrhoea
Patient was taking Abatacept (View Usage). Patient had the following side effects: dehydration, diarrhoea on Jun 23, 2010 from MEXICO Additional patient health information: Female patient , 21 years of age, was diagnosed with systemic lupus erythematosus and. Abatacept dosage: . During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), HYDROXYCHLOROQUINE (View Hydroxychloroquine Review and Hydroxychloroquine Label ). Patient was hospitalized.

6794712-2 | Renal Failure
Adverse event was reported on Jun 22, 2010 by a Female patient taking Abatacept (View Usage) (Dosage: ) was diagnosed with systemic lupus erythematosus and. Location: INDIA , 25 years of age, After Abatacept was administered, patient had the following side effects: renal failure. During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), PANTOCID (View Pantocid Review and Pantocid Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), HYDROXYCHLOROQUINE (View Hydroxychloroquine Review and Hydroxychloroquine Label ), ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ). Patient was hospitalized.

6780443-1 | Appendicitis
on Jun 14, 2010 Male patient from UNITED STATES , 61 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Abatacept (View Usage). Patient experienced the following unwanted or unexpected effects: appendicitis (What is appendicitis?). Abatacept dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), FLOMAX (View Flomax Review and Flomax Label ), FLUTICASONE (View Fluticasone Review and Fluticasone Label ), EXCEDRIN (MIGRAINE) (View Excedrin (migraine) Review and Excedrin (migraine) Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), TRAMADOL (View Tramadol Review and Tramadol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6774712-9 | Psoriasis
on Jun 07, 2010 Male patient from ITALY , 52 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Abatacept (View Usage). Patient had the following side effects: psoriasis. Abatacept dosage: Weeks 0,2,4and8.. During the same period patient was treated with SALAZOPYRIN (View Salazopyrin Review and Salazopyrin Label ), HYDROXYCHLOROQUINE (View Hydroxychloroquine Review and Hydroxychloroquine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ), ADALIMUMAB (View Adalimumab Review and Adalimumab Label ), INFLIXIMAB (View Infliximab Review and Infliximab Label ), ETANERCEPT (View Etanercept Review and Etanercept Label ), ANAKINRA (View Anakinra Review and Anakinra Label ).

6768915-7 | Cholangitis, Pancreatitis
Patient was taking Abatacept (View Usage). After Abatacept was administered, patient had the following side effects: cholangitis, pancreatitis on Jun 07, 2010 from GERMANY Additional patient health information: Female patient , 56 years of age, weighting 165.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Abatacept dosage: .

6766635-6 | Dehydration, Diarrhoea
Adverse event was reported on Jun 04, 2010 by a Female patient taking Abatacept (View Usage) (Dosage: ) was diagnosed with systemic lupus erythematosus and. Location: MEXICO , 21 years of age, Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea. During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), HYDROXYCHLOROQUINE (View Hydroxychloroquine Review and Hydroxychloroquine Label ). Patient was hospitalized.

6765922-5 | Oedema Peripheral
on Jun 08, 2010 Female patient from UNITED STATES , 58 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Abatacept (View Usage). Patient had the following side effects: oedema peripheral. Abatacept dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), RISEDRONATE SODIUM (View Risedronate Sodium Review and Risedronate Sodium Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6765917-1 | Cholangitis, Pancreatitis
on Jun 07, 2010 Female patient from GERMANY , 56 years of age, weighting 165.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Abatacept (View Usage). After Abatacept was administered, patient had the following side effects: cholangitis, pancreatitis. Abatacept dosage: .

6765915-8 | Chest Pain, Dyspnoea
Patient was taking Abatacept (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), dyspnoea on Jun 08, 2010 from BRAZIL Additional patient health information: Male patient , 70 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Abatacept dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6759550-5 | Hepatic Enzyme Increased
Adverse event was reported on Jun 01, 2010 by a Male patient taking Abatacept (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: FRANCE , 62 years of age, Patient had the following side effects: hepatic enzyme increased. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), STAGID (1 Df=700 Units Not Specified) (View Stagid Review and Stagid Label ). Patient was hospitalized.

6759545-1 | Atrial Fibrillation, Cardiac Failure, Foot Deformity, Mitral Valve Incompetence
on May 27, 2010 Female patient from JAPAN , 49 years of age, weighting 119.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), prophylaxis, prophylaxis against gastrointestinal ulcer and was treated with Abatacept (View Usage). After Abatacept was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cardiac failure, foot deformity, mitral valve incompetence. Abatacept dosage: . During the same period patient was treated with PREDONINE (12sep09 5mg Sid) (View Predonine Review and Predonine Label ), RHEUMATREX (Formulation - Capsule Rheumatrex Tab 4mg/wk Po 05dec09-24jan10) (View Rheumatrex Review and Rheumatrex Label ), LORCAM (Formulation - Tablet) (View Lorcam Review and Lorcam Label ), FOLIAMIN (Formulation - Tablet From 07dec09) (View Foliamin Review and Foliamin Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), FLURBIPROFEN (View Flurbiprofen Review and Flurbiprofen Label ), MUCOSTA (Formulation - Tablet Tab 150mg/day Po) (View Mucosta Review and Mucosta Label ). Patient was hospitalized.

6740351-9 | Ventricular Extrasystoles
on May 19, 2010 Male patient from CHINA , 45 years of age, was diagnosed with systemic lupus erythematosus and was treated with Abatacept (View Usage). Patient experienced the following unwanted or unexpected effects: ventricular extrasystoles. Abatacept dosage: 1 Df=0.75 Units Not Specified. During the same period patient was treated with MYCOPHENOLATE MOFETIL (1 Df=1.5 Units Not Specified) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE (Also Taken As Conmed From 22apr10:45mgqn) (View Prednisone Review and Prednisone Label ), BENAZEPRIL HYDROCHLORIDE (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ), NORVASC (View Norvasc Review and Norvasc Label ), CALTRATE + D (1 Df=0.6 Units Not Specified) (View Caltrate + D Review and Caltrate + D Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6737033-6 | Gastritis
Patient was taking Abatacept (View Usage). Patient had the following side effects: gastritis on May 18, 2010 from POLAND Additional patient health information: Female patient , 34 years of age, was diagnosed with glomerulonephritis proliferative and. Abatacept dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), CALCORT (View Calcort Review and Calcort Label ), NITRENDIPINE (View Nitrendipine Review and Nitrendipine Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ). Patient was hospitalized.